Fast Five Quiz: Opioid-Induced Constipation

B.S. Anand, MD


October 15, 2020

There are four approaches to the prevention and treatment of opioid-induced constipation: (1) over-the-counter agents or agents approved for the treatment of chronic constipation (linaclotide, prucalopride, and lubiprostone, the latter being approved for the treatment of opioid-induced constipation in patients with chronic, noncancer pain); (2) use of alternative opioids, such as tapentadol; (3) use of a fixed combination of opioid and opioid antagonist such as oxycodone-naloxone; and finally, (4) use of PAMORAs (methylnaltrexone, naloxegol, naldemedine). A recent meta-analysis found that approved doses of PAMORAs confer greater therapeutic response and fewer adverse effects in opioid-induced constipation than all of the three other approaches.

Learn more about the prevention and treatment of opioid-induced constipation.

Editor's Recommendations


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.